Metavision Arruzafa S.L.

Cordoba 14 trials 4 recruiting

14 Registered trials

4 Currently recruiting

Organisation

Metavision Arruzafa S.L.

Location

Cordoba, Spain

Identifier

ORG-100051262

Address

Avenida De La Arruzafa 9, 14012, Spain

Departments

204: Instituto de Oftalmología La Arruzafa
2106: Oftalmología
3801: Oftalmología
473: Oftalmología
724002: Oftalmología
Oftalmología
Ophtalmology
Ophthalmology
UC-1597043: Oftalmología

Clinical trials at this site (14)

Search interface

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy Pending

2023-505750-17-00 Neovascular age-related macular degeneration 4
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneratio… Pending

2025-523704-77-00 Geographic atrophy secondary to age-related macular deg 4
EFFICACY OF FARICIMAB IN PATIENTS WITH SUBRETINAL HYPER-REFLECTIVE MATERIAL Recruiting

2025-522701-38-00 SUBRETINAL HYPERREFLECTIVE MATERIAL 6 2026-02-26
Study to Assess the Injection Burden, Safety, Efficacy, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) … Recruiting

2024-512298-28-00 Neovascular age-related macular degeneration 11 2025-12-18
A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution… Recruiting

2025-522291-83-00 Atopic Keratoconjunctivitis 5 2025-11-27
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
A Safety, and Tolerability Study of VRDN-003 in Participants with Thyroid Eye Disease (TED) Ended

2024-519417-57-00 Thyroid eye disease 5 2025-06-25
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Participants with Dry Age-Related Macular Degeneration… Ended

2024-515022-88-00 Dry Age-Related Macular Degeneration (AMD) with geograp 5 2025-03-03
A Safety and Tolerability Study of VRDN-001 in Persons with Thyroid Eye Disease (TED) Ended

2023-507563-19-00 Thyroid eye disease 5 2024-11-05
A Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) in Subjects with Fuchs Dystrophy Ended

2022-502643-35-00 Fuchs Endothelial Corneal Dystrophy 5 2023-08-09
A Study to Investigate the Safety and Effectiveness of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects with Fuchs Endothelial … Ended

2024-511752-40-00 Fuchs Endothelial Corneal Dystrophy 5 2023-05-05
An Open-Label Extension Study for Patients who Previously Completed Study ISEE2008 (GATHER2) Ended

2024-515185-13-00 geographic atrophy 5 2022-12-21
A multiple ascending dose (MAD) safety, tolerability and efficacy study of VRDN-001, a humanized monoclonal antibody directed against the IG… Ended

2024-512244-36-00 Thyroid eye disease (TED) 10 2022-10-25
Evaluation of the efficacy and safety of topical treatment on clinical signs and symptoms of dry eye disease associated with moderate meibom… Ended

2024-518093-13-00 Dry Eye and Meibomian Gland Dysfunction 6 2021-10-26